Finance

Lists
BLISSGVS:NSE
Bliss GVS Pharma Ltd
₹558.50
-3.56%
(-20.60) 1D
Aug 24, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BLISSGVS...
Open
₹578.00
High
₹583.50
Low
₹551.00
Mkt. cap
59.35B
Avg. vol.
0.00
Volume
329.74K
Dividend
0.27%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
44.30
52-wk high
₹602.45
52-wk low
₹118.00
EPS
₹12.61
Shares outstanding
103.15M
No. of employees
1K
Open
₹578.00
High
₹583.50
Low
₹551.00
Mkt. cap
59.35B
Avg. vol.
0.00
Volume
329.74K
Dividend
0.27%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
44.30
52-wk high
₹602.45
52-wk low
₹118.00
EPS
₹12.61
Shares outstanding
103.15M
No. of employees
1K
About Bliss GVS Pharma Ltd
CEO-
Employees1.03K
Founded1984
Headquarters-
SectorPharmaceutical industry
Websiteblissgvs.com
Last report
Aug 12, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.86B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.44B
2.18B
2.57B
2.86B
Cost of goods sold
1.18B
1.02B
1.36B
1.14B
Cost of revenue
1.18B
1.02B
1.36B
1.14B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
333.51M
359.36M
1.00B
430.47M
Operating expense
1.03B
901.49M
844.80M
1.05B
Total operating expenses
2.21B
1.92B
2.21B
2.19B
Operating income
234.96M
264.40M
363.12M
664.63M
Other non operating income
201.78M
184.56M
-597.23M
96.00M
EBT including unusual items
406.33M
408.96M
449.50M
754.83M
EBT excluding unusual items
406.33M
434.09M
431.08M
754.83M
Income tax expense
120.44M
161.17M
79.51M
241.11M
Effective tax rate
29.64%
39.41%
17.69%
31.94%
Other operating expenses
612.37M
458.64M
-244.91M
516.84M
Net income
272.50M
232.66M
355.75M
500.97M
Net profit margin
11.15%
10.66%
13.84%
17.54%
Earnings per share
-
-
-
-
Interest and investment income
-
-
167.47M
-
Interest expense
-30.42M
-14.86M
-20.08M
-5.79M
Net interest expenses
-30.42M
-14.86M
147.40M
-5.79M
Depreciation and amortization charges
82.62M
83.50M
86.71M
99.38M
EBITDA
317.28M
326.86M
431.12M
732.63M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps